Neuronal exosomal miR-25-3p attenuates M1 microglial activation and neurotoxicity by targeting TLR4 to regulate the NF-κB signaling pathway - Top-Institutions - MDSpire

Neuronal exosomal miR-25-3p attenuates M1 microglial activation and neurotoxicity by targeting TLR4 to regulate the NF-κB signaling pathway

  • By

  • Guangjun Hu

  • Sarulatuya

  • Siyu Du

  • Zhile Huang

  • Xinyi Tang

  • June 3, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    NewYork-Presbyterian Hospital–Columbia and Cornell
    NewYork-Presbyterian Hospital–Columbia and Cornell

    New York, NY

    Key Differentiators

    • Neurology
    • Neurosurgery

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Neurosurgery

  • #3

    University of Genoa
    University of Genoa

    Genoa, Italy

    Key Differentiators

    • Neurology

  • #4

    University of Queensland
    University of Queensland

    Brisbane, Australia

    Key Differentiators

    • Neurology

  • #5

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurology

Original Source(s)

Neuronal exosomal miR-25-3p attenuates M1 microglial activation and neurotoxicity by targeting TLR4 to regulate the NF-κB signaling pathway

  • by Guangjun Hu, Sarulatuya, Siyu Du, Zhile Huang, Xinyi Tang

  • June 3, 2026

Related Content

Efficacy and safety of ozone autohemotherapy for zoster-associated pain: a meta-analysis and trial sequential analysis

The efficacy of acupuncture for depression-associated chronic pain: a systematic review and meta-analysis

Early Neurodevelopmental Outcomes in Pediatric Congenital Heart Disease

In a multicenter registry study, genetic diagnoses were associated with substantially lower cognitive, language, and motor scores; while birth weight, surgical timing, hospitalization burden, and caregiver education were also associated with outcomes.